Shine Investment Advisory Services’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$273K Hold
3,133
0.09% 111
2020
Q2
$281K Hold
3,133
0.1% 99
2020
Q1
$312K Hold
3,133
0.14% 84
2019
Q4
$360K Hold
3,133
0.14% 88
2019
Q3
$395K Hold
3,133
0.19% 73
2019
Q2
$377K Hold
3,133
0.17% 76
2019
Q1
$274K Hold
3,133
0.13% 95
2018
Q4
$313K Hold
3,133
0.15% 78
2018
Q3
$359K Hold
3,133
0.19% 74
2018
Q2
$281K Sell
3,133
-50
-2% -$4.22K 0.14% 81
2018
Q1
$233K Sell
3,183
-159
-5% -$10.9K 0.12% 91
2017
Q4
$194K Hold
3,342
0.1% 104
2017
Q3
$150K Hold
3,342
0.08% 112
2017
Q2
$132K Buy
+3,342
New +$137K 0.07% 119

Other funds holding HAE

Shine Investment Advisory Services's HAE Position: Q3 2020 in Review

Shine Investment Advisory Services held its Haemonetics (HAE) position steady in Q3 2020 at 3,133 shares worth $273K. The position accounts for 0.09% of the portfolio, ranked #111.

Shine Investment Advisory Services first reported a position in HAE in Q2 2017 and has held it in 14 quarters since. The position peaked at $395K in Q3 2019. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

  • Shine Investment Advisory Services held 3,133 shares of Haemonetics worth $273K as of Q3 2020.
  • Shine Investment Advisory Services left its Haemonetics share count unchanged in Q3 2020.
  • Haemonetics made up 0.09% of Shine Investment Advisory Services's portfolio in Q3 2020, its #111 holding.
  • Shine Investment Advisory Services first reported a position in Haemonetics in Q2 2017 and has held it in 14 quarters since.
  • Shine Investment Advisory Services's Haemonetics position peaked at $395K in Q3 2019.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.